[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-333958-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-333958-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","bidirectional-effects-of-morphine-on-pancreatic-cancer-progression-via-the-p38jnk-pathway","Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway","","Cancer patients frequently use morphine for severe advanced pain, yet its influence on pancreatic cancer progression remains insufficiently characterized. This study evaluates morphine’s effects and underlying mechanisms in vitro using CCK-8, colony formation, EdU, wound healing, and transwell migration/invasion assays, and in vivo using tumor xenografts. Western blotting assesses signaling-pathway protein changes. Results show low-dose morphine (25 μM) promotes progression, whereas high-dose morphine (100 μM) inhibits it.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/bidirectional-effects-of-morphine-on-pancreatic-cancer-progression-via-the-p38jnk-pathway/333958/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/bidirectional-effects-of-morphine-on-pancreatic-cancer-progression-via-the-p38jnk-pathway/333958.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main research question of this study?","Question",{"text":63,"@type":64},"The study asks how morphine affects pancreatic cancer progression and through which mechanisms it may act.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do different morphine concentrations impact pancreatic cancer cells?",{"text":68,"@type":64},"Low concentration (25 μM) promotes pancreatic cancer cell proliferation and oncogenic behaviors, while high concentration (100 μM) produces time-dependent inhibition and stronger suppressive effects.",{"name":70,"@type":61,"acceptedAnswer":71},"What pathway is implicated in morphine’s bidirectional effects?",{"text":72,"@type":64},"Morphine is proposed to modulate pancreatic cancer progression bidirectionally through the p38/JNK signaling pathway, supported by protein-level analyses using Western blot.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},333958,1790198501,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nBidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway  \nJing Ning1,3, Xiubing Chen2,3, Qing Li1,3, Dan Yang1, Chunxiao Xie1, Shanyu Qin1􀀍 & Haixing Jiang1􀀍  \nCancer patients commonly use morphine to alleviate advanced pain. Studies have shown that morphine may influence and intervene in the malignancy of various cancers, but its role and effects on pancreatic cancer are less studied. This study aims to examine how morphine affects pancreatic cancer and its possible mechanisms. In vitro experiments were conducted using the CCK-8 experiment, colony formation experiment, EdU test, wound healing experiment, and transwell migration and invasion experiment. Tumor xenograft tests were employed to investigate the in vivo impact of morphine on pancreatic cancer. The Western blot (WB) assay was used to detect possible changes in key proteins of the related signaling pathway. Our experimental results showed that low concentrations of morphine (25 µM) promoted the progression of pancreatic cancer, while high concentrations of morphine  \n(100 µM) inhibited its progression. Further, we demonstrated that morphine may interfere with the progression of pancreatic cancer by acting on the p38/JNK signaling pathway. Morphine may affect pancreatic cancer progression through the p38/JNK pathway in a bidirectional manner at different concentrations.  \nThe five-year survival rate for pancreatic cancer is less than 10%, making it one of the deadliest cancers1. It accounts for over 90% of pancreatic cancers, primarily pancreatic ductal adenocarcinoma2. Surgical resection, chemotherapy, and radiotherapy are the current treatments for pancreatic cancer3. Medications such as morphine are generally used to manage severe pain associated with advanced pancreatic cancer4. It appears that morphine may significantly influence the growth of tumors in cancer patients.  \nMorphine is used to treat severe pain, both acutely and chronically. The analgesic and sedative effects of morphine are primarily produced by activating the Mu opioid receptor5. However, morphine’s effect on cancer malignancy has been contradictory in studies. Some studies have shown that cancer cells are inhibited by morphine. For example, Zhang et al. found that using clinical concentrations of morphine (10µM in vitro experiments), tumorigenicity of hepatocellular cancer cells was inhibited6. Chen et al. demonstrated that apoptosis and blocking the cell cycle are two mechanisms by which morphine (10µMin vitro experiments) inhibits the progression of breast cancer7. On the other hand, however, morphine also promotes cancer progression. A higher level of survivin increases the aggressiveness of renal cell carcinoma caused by morphine (50µM in vitro experiments)8. Nguyen et al. found that cancer progression was stimulated and survival was impaired in transgenic mice with breast cancer by morphine (subcutaneously injected at a concentration of 1.5 mg kg−1 day−1in vivo experiments)9. Esophageal cancer cell migration and growth are stimulated by morphine (3 mg kg−1 day−1 orally) in a preclinical model10. Most scientists believe that these differences in outcomes may be due to differences in dose or route of administration11, 12.  \nIn advanced pancreatic cancer patients, morphine is commonly prescribed. However, it is unclear how morphine impacts the malignancy of pancreatic cancer and its underlying mechanisms. Consequently, it is imperative to investigate morphine’s effects on pancreatic cancer progression and its possible mechanisms of action.  \n1Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.  \n2Department of Gastroenterology, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, China.  \n3These authors contributed equally: Jing Ning, Xiubing Chen and Qing Li. 􀀍 email: [qinshanyu@gxmu.edu.cn](qinshanyu@gxmu.","cbCaitaiVRKHtKYL","https://ap.wps.com/l/cbCaitaiVRKHtKYL","pdf",2547794,11,"English","# Introduction\n# Methods\n## In vitro assays\n## In vivo xenograft model\n# Results\n## Effects on cell proliferation\n## Effects on migration and invasion\n# Mechanistic analysis\n## Western blot of p38/JNK pathway proteins","[{\"question\":\"What is the main research question of this study?\",\"answer\":\"The study asks how morphine affects pancreatic cancer progression and through which mechanisms it may act.\"},{\"question\":\"How do different morphine concentrations impact pancreatic cancer cells?\",\"answer\":\"Low concentration (25 μM) promotes pancreatic cancer cell proliferation and oncogenic behaviors, while high concentration (100 μM) produces time-dependent inhibition and stronger suppressive effects.\"},{\"question\":\"What pathway is implicated in morphine’s bidirectional effects?\",\"answer\":\"Morphine is proposed to modulate pancreatic cancer progression bidirectionally through the p38/JNK signaling pathway, supported by protein-level analyses using Western blot.\"}]","Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway | PDF",1790004764,28]